TF Equities Limited today announced it plans to invest $350 million in biotechnology and other emerging growth companies through TFE Ventures, the company’s venture investment arm. Additionally, TFE will extend its leadership as a venture capital investor with an expanded team that leverages expertise across venture capital investing and business development.
“Our objective is to extend the breadth and depth of TFE’s support for the development of cutting-edge technologies. Building on our current investments and proven track-records, we continue to look to identify emerging companies that are advancing technologies”, said Tyler Friedrichson, Chief Investment Officer.
TF Equities Investment Strategy
TF Equities Limited will seek to invest available capital of $350 million in promising early-stage technology companies. In leveraging an equity investment model, TFE can support a broad range of early biotechnology research and product development opportunities.
“We will support an energized community of biotech entrepreneurs who are progressing the understanding of plant based pharmaceutical therapeutics,” said TF Equities CEO, Mr. Thorsten Frank
Areas of interest for TFE include memory, appetite, pain sensation, stress response, energy balance and metabolism, anxiety, immune functions, thermoregulation, and sleep. TFE will continue to invest across a broad range of therapeutic technologies that have the potential to transform drug discovery.
About TF Equities
TF Equities Limited, or "TFE", is a Global Investment Management Company with offices in Switzerland, Hong Kong, and Singapore. As a company, we focus on providing high-end services and in-depth advice to both Institutional and Private Clients globally.
Our mission is to improve the financial future of those we serve. Based in Switzerland as well as Hong Kong and Singapore we are a global investment advisers for individuals and private groups, who wish to grow and sustain wealth through a dynamic and distributed set of investment vehicles.
Media Contact:
info@tfequities.com
8706 Meilen, Switzerland
9/F, Hong Kong Diamond Exchange Building, 8-10 Duddell Street, Central, Hong Kong
Singapore: 18G Telok Kurau di Singapore
Switzerland: +41 225330913
Hong Kong: +852 58081869
Email: info@tfequities.com
TF Equities Limited to Expand Venture Investing with $350 Million Commitment
www.tfequities.com
Brennon Murfey - | Manager